Delivery Order SPE2DB22D1017-SPE2DB25FYPYM
Award Date 9/4/25
Potential Completion Date 9/25/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Bosulif 400 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $11,815.63 and completion deadline of August 29, 2025. This is a non-set-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $70,893.78 to AmerisourceBergen Drug Corp for 30-tablet supplies of Bosulif 400 mg, a pharmaceutical product used in oncology treatment. This non-competitive, firm fixed-price delivery order was awarded on September 4, 2025, with a completion date of September 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child purchase order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for BOSULIF 400 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price contract, utilizing no set-aside designation, represents a competitive award under the company's broader pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $11,408.90 to AmerisourceBergen Drug Corp for the supply of Bosulif 100 mg tablets (120-count) on August 21, 2025, with completion expected by September 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Bosulif 500 mg tablets (30-count units) under a firm fixed-price contract. The order carries a ceiling value of $11,301.40 and is scheduled for completion by September 25, 2025. This is a competitively awarded, non-set-aside delivery order with performance directed to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of BOSULIF 400 mg tablets (30-count packages) with a ceiling value of $23,631.26. The contract is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BOSULIF 400 mg tablets (30-count) with a ceiling value of $11,815.63. The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order under a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BOSULIF 100 mg tablets (120-count supply) on September 4, 2025, with a ceiling value of $17,113.35. This firm fixed-price contract represents a non-competitive set-aside delivery order with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. BOSULIF is a prescription medication used in oncology treatment, reflecting the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 400 mg tablets of Bosulif (a tyrosine kinase inhibitor used in cancer treatment) with a ceiling value of $59,078.15. This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of September 15, 2025. The contract carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $11,815.63 to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 24, 2025. The awardee, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. Bosulif is a tyrosine kinase inhibitor used in the treatment of...